Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
QAAClass II

Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens

21 CFR 866.3376 / Microbiology

QAA is the FDA product code for Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens, a class II device type, regulated under 21 CFR 866.3376. FDA's definition for this code reads: "A Coccidioides spp. nucleic acid detection system for respiratory specimens is a qualitative test for the detection of Coccidioides spp. nucleic acids directly in clinical respiratory specimens from patients with signs and symptoms of coccidioidomycosis and suspicion of infection". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.

Classification record

Product code
QAA
Device name
Coccidioides Spp. Nucleic Acid Detection System For Respiratory Specimens
FDA definition
A Coccidioides spp. nucleic acid detection system for respiratory specimens is a qualitative test for the detection of Coccidioides spp. nucleic acids directly in clinical respiratory specimens from patients with signs and symptoms of coccidioidomycosis and suspicion of infection.
Regulation
21 CFR 866.3376
Device class
Class II
Review panel
Microbiology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
1
Ingested recalls
0

Clearances, product code QAA

By decision year
1 clearance under product code QAA with a decision year between 2017 and 2017, 2017 the highest year at 1.
Show the numbers
510(k) clearances under FDA product code QAA by decision year
YearClearances
20171

Applicants with the most clearances

Product code QAA
Applicants holding the most 510(k) clearances under product code QAA
ApplicantClearances
Dxna, LLC1

Companies listing this code with FDA

Companies whose registered establishments list this code